Publication | Closed Access

In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units

Gram-negative Bacilli IsolatedHealth SciencesMedicineSepsisAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundVitro ActivityPharmacologyClinical MicrobiologyAntimicrobial ResistanceNovel Siderophore CephalosporinDrug Resistance